1. Structural Biology and Molecular Biophysics
Download icon

Acidic C-terminal domains autoregulate the RNA chaperone Hfq

  1. Andrew Santiago-Frangos
  2. Jeliazko R Jeliazkov
  3. Jeffrey J Gray
  4. Sarah A Woodson  Is a corresponding author
  1. Johns Hopkins University, United States
Research Article
  • Cited 23
  • Views 1,880
  • Annotations
Cite this article as: eLife 2017;6:e27049 doi: 10.7554/eLife.27049

Abstract

The RNA chaperone Hfq is an Sm protein that facilitates base pairing between bacterial small RNAs (sRNAs) and mRNAs involved in stress response and pathogenesis. Hfq possesses an intrinsically disordered C-terminal domain (CTD) that may tune the function of the Sm domain in different organisms. In Escherichia coli, the Hfq CTD increases kinetic competition between sRNAs and recycles Hfq from the sRNA-mRNA duplex. Here, de novo Rosetta modeling and competitive binding experiments show that the acidic tip of the E. coli Hfq CTD transiently binds the basic Sm core residues necessary for RNA annealing. The CTD tip competes against non-specific RNA binding, facilitates dsRNA release, and prevents indiscriminate DNA aggregation, suggesting that this acidic peptide mimics nucleic acid to auto-regulate RNA binding to the Sm ring. The mechanism of CTD auto-inhibition predicts the chaperone function of Hfq in bacterial genera and illuminates how Sm proteins may evolve new functions.

Article and author information

Author details

  1. Andrew Santiago-Frangos

    Cell, Molecular and Developmental Biology and Biophysics Program, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9615-065X

  2. Jeliazko R Jeliazkov

    Program in Molecular Biophysics, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4249-1955

  3. Jeffrey J Gray

    Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6380-2324

  4. Sarah A Woodson

    T. C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, United States
    For correspondence
    swoodson@jhu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0170-1987

Funding

National Institute of General Medical Sciences (R01 GM120425-01)

  • Sarah A Woodson

National Institute of General Medical Sciences (R01 GM078221)

  • Jeffrey J Gray

National Institute of General Medical Sciences (T32 GM008403-25)

  • Jeliazko R Jeliazkov

National Institute of General Medical Sciences (T32 GM007231-40)

  • Andrew Santiago-Frangos

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Ben F Luisi, University of Cambridge, United Kingdom

Publication history

  1. Received: March 22, 2017
  2. Accepted: August 3, 2017
  3. Accepted Manuscript published: August 9, 2017 (version 1)
  4. Version of Record published: September 20, 2017 (version 2)
  5. Version of Record updated: October 12, 2017 (version 3)

Copyright

© 2017, Santiago-Frangos et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,880
    Page views
  • 461
    Downloads
  • 23
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Categories and tags

Research organism

Further reading

    1. Structural Biology and Molecular Biophysics

    Differential impact of BTK active site inhibitors on the conformational state of full-length BTK

    Raji E Joseph et al.
    Research Article Updated

    Bruton’s tyrosine kinase (BTK) is targeted in the treatment of B-cell disorders including leukemias and lymphomas. Currently approved BTK inhibitors, including Ibrutinib, a first-in-class covalent inhibitor of BTK, bind directly to the kinase active site. While effective at blocking the catalytic activity of BTK, consequences of drug binding on the global conformation of full-length BTK are unknown. Here, we uncover a range of conformational effects in full-length BTK induced by a panel of active site inhibitors, including large-scale shifts in the conformational equilibria of the regulatory domains. Additionally, we find that a remote Ibrutinib resistance mutation, T316A in the BTK SH2 domain, drives spurious BTK activity by destabilizing the compact autoinhibitory conformation of full-length BTK, shifting the conformational ensemble away from the autoinhibited form. Future development of BTK inhibitors will need to consider long-range allosteric consequences of inhibitor binding, including the emerging application of these BTK inhibitors in treating COVID-19.

    1. Structural Biology and Molecular Biophysics

    Small-Molecule Inhibitors: Disrupting enzyme fluidity

    Ganesh Srinivasan Anand
    Insight

    A combination of X-ray crystallography, NMR, and mass spectrometry has revealed how diverse small-molecule inhibitors bind Bruton’s tyrosine kinase and alter the conformation of this enzyme.

    1. Immunology and Inflammation
    2. Structural Biology and Molecular Biophysics

    Properdin oligomers adopt rigid extended conformations supporting function

    Dennis V Pedersen et al.
    Research Article

    Properdin stabilizes convertases formed upon activation of the complement cascade within the immune system. The biological activity of properdin depends on the oligomerization state, but whether properdin oligomers are rigid and how their structure links to function remains unknown. We show by combining electron microscopy and solution scattering, that properdin oligomers adopt extended rigid and well-defined conformations that are well approximated by single models of apparent n-fold rotational symmetry with dimensions of 230-360 Å. Properdin monomers are pretzel shaped molecules with limited flexibility. In solution, properdin dimers are curved molecules whereas trimers and tetramers are close to being planar molecules. Structural analysis indicates that simultaneous binding through all binding sites to surface linked convertases is unlikely for properdin trimer and tetramers. We show that multivalency alone is insufficient for full activity in a cell lysis assay. Hence, the observed rigid extended oligomer structure is an integral component of properdin function.